Product/Service

SILSOL® Silica-Based Drug Delivery Technology

Source: Grace

Grace, API synthesis, chromatographic media & packing equipment

Grace’s SILSOL® Silica-based Drug Delivery Technology was engineered to bring together advanced silica technologies with challenging active pharmaceutical ingredients (APIs) to help more effectively formulate a large class of poorly soluble but otherwise promising compounds.

SILSOL®​ Silica​ for Drug Delivery Systems

SILSOL® silica was engineered to bring together advanced silica technologies with challenging active pharmaceutical ingredients to help more effectively formulate large class of poorly soluble but otherwise promising compounds.​    

  • Enhanced bioavailability - through delivery of the amorphous form of drugs
  • Stability - amorphous solid dispersions prevent crystallization/re-crystallization
  • Pharmacopeia acceptance - GMP manufactured silica
  • Scalability -  Grams to tons quantities
  • FDA Compliance – Materials listed in FDA inactive ingredient database